Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q619603> ?p ?o }
Showing triples 1 to 37 of
37
with 100 triples per page.
- Q619603 subject Q7484882.
- Q619603 subject Q8805811.
- Q619603 subject Q9546190.
- Q619603 abstract "Methyl aminolevulinate (MAL) is a drug used as a sensitizer in photodynamic therapy. It is a prodrug that is metabolized to protoporphyrin IX. It is marketed as Metvix.Metvix cream is applied topically and some time later the skin is illuminated with a proprietary red light (630 nm) source (medical lamp 'Aktilite') to activate the photosensitiser.Metvix is developed by Photocure and Galderma has bought all rights to Metvix.".
- Q619603 atcPrefix "L01".
- Q619603 atcSuffix "XD03".
- Q619603 casNumber "33320-16-0".
- Q619603 drugbank "DB00992".
- Q619603 iupacName "methyl 5-amino-4-oxo-pentanoate".
- Q619603 pubchem "16052023".
- Q619603 thumbnail Methyl_aminolevulinate.svg?width=300.
- Q619603 wikiPageWikiLink Q1428072.
- Q619603 wikiPageWikiLink Q18388377.
- Q619603 wikiPageWikiLink Q192102.
- Q619603 wikiPageWikiLink Q581008.
- Q619603 wikiPageWikiLink Q603741.
- Q619603 wikiPageWikiLink Q619815.
- Q619603 wikiPageWikiLink Q6535862.
- Q619603 wikiPageWikiLink Q7187731.
- Q619603 wikiPageWikiLink Q7484882.
- Q619603 wikiPageWikiLink Q809758.
- Q619603 wikiPageWikiLink Q8805811.
- Q619603 wikiPageWikiLink Q9546190.
- Q619603 atcPrefix "L01".
- Q619603 atcSuffix "XD03".
- Q619603 casNumber "33320".
- Q619603 drugbank "DB00992".
- Q619603 iupacName "methyl 5-amino-4-oxo-pentanoate".
- Q619603 pubchem "16052023".
- Q619603 type ChemicalSubstance.
- Q619603 type Drug.
- Q619603 type ChemicalObject.
- Q619603 type Thing.
- Q619603 type Q8386.
- Q619603 comment "Methyl aminolevulinate (MAL) is a drug used as a sensitizer in photodynamic therapy. It is a prodrug that is metabolized to protoporphyrin IX. It is marketed as Metvix.Metvix cream is applied topically and some time later the skin is illuminated with a proprietary red light (630 nm) source (medical lamp 'Aktilite') to activate the photosensitiser.Metvix is developed by Photocure and Galderma has bought all rights to Metvix.".
- Q619603 label "Methyl aminolevulinate".
- Q619603 depiction Methyl_aminolevulinate.svg.